Can-Fite BioPharma Ltd. Total Revenue

• Can-Fite BioPharma Ltd. showed a decrease of -39.9% in Total Revenue from 2024 to 2025.
• This data is from Can-Fite BioPharma Ltd.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), Can-Fite BioPharma Ltd.'s Total Revenue has declined by 89.4%.
• Historical annual values: Fiscal year 2025: $405.0 thousand | Fiscal year 2024: $674.0 thousand | Fiscal year 2023: $743.0 thousand | Fiscal year 2022: $810.0 thousand | Fiscal year 2021: $853.0 thousand | Fiscal year 2020: $763.0 thousand | Fiscal year 2019: $2.03 million | Fiscal year 2018: $3.82 million.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026